tirzepatide tablet v sublingual Oral Pill: FDA-Approved Options 1 and GIP mechanism in a daily Tirzepatide Oral Rapid Dissolve Sublingual
Description
This is not treatment failure
Most patients experience robust weight loss for 612 months, then notice slowing between months 1218
A post hoc analysis of that trial found that 82% of tirzepatide-treated participants had already lost 5% or more of their body weight by week 12
Common side effects: Nausea Vomiting Diarrhea Constipation Mild abdominal discomfort Why side effects occur: These issues are most likely during the dose escalation phase, which is why the stepwise tirzepatide dosing schedule is so important
Understanding your genetic profile helps your PlexusDx provider tailor supplementation recommendations specifically to your biochemistry
Tirzepatides weight loss potential was proved in the SURMOUNT clinical program, which consisted of several phase 3 trials
